Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 313
Selected: 0
NCT IDTitle
NCT02064556CKD-330 Drug-Drug Interaction Study (Amlodipine)
NCT03246880Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients
NCT01842269Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kidney Transplant Patients
NCT02548286Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs
NCT05881213Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults
NCT01496261Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd Trial
NCT06399068Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed Conditions
NCT02494284Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation
NCT05238948CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects
NCT06916793A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia
NCT02288338CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers
NCT03569579CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1)
NCT02648854Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers
NCT03583905Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet
NCT04667975The Purpose of Study is to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Who Failed to Standard Therapy
NCT05549401Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348
NCT05043467Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus
NCT05526742A Study to Evaluate the Relative Bioavailability of Formulations of CKD-510 and to Assess the Effect of Food on the CKD-510 Tablet Formulation in Healthy Subjects
NCT01956201Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin
NCT06709807Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy Volunteers
NCT04676893Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects
NCT02066207CKD-337 Drug Interaction Study
NCT04083872Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
NCT05587699The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A
NCT07258745Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants
NCT02002611Drug-drug Interaction Study(Lobeglitazone, Warfarin)
NCT01019941Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer
NCT04448223A Clinical Study to Evaluate the Efficacy and Safety of CKD-351
NCT02565368A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers
NCT04345796Pharmacological Reduction of Right Ventricular Enlargement
NCT03431623CKD-11101 Phase 3 SC Study
NCT02805738Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet
NCT04840745The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1
NCT02623868Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject.
NCT04102943Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.
NCT03627182Efficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 Diabetes
NCT05834595A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828
NCT06695572Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers
NCT07215637Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors
NCT06627322A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)
NCT02005744A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function
NCT02827890CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)
NCT06430047Efficacy and Safety of EsoDuo®
NCT04883658A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)
NCT01028859Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers
NCT04019743Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers
NCT06204107A Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379
NCT05741437A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378
NCT01756430Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential Hypertension
NCT03346187A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337